NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $313,952 | +5.3% | 3,082 | +4.3% | 0.26% | +5.8% |
| Q2 2023 | $298,107 | +12.3% | 2,954 | +2.4% | 0.24% | +4.3% |
| Q1 2023 | $265,530 | +7.9% | 2,886 | +6.4% | 0.23% | -3.3% |
| Q4 2022 | $246,123 | +20.1% | 2,713 | +0.4% | 0.24% | +10.6% |
| Q3 2022 | $205,000 | -10.5% | 2,702 | -0.4% | 0.22% | -3.6% |
| Q2 2022 | $229,000 | -4.6% | 2,712 | -0.7% | 0.22% | +16.0% |
| Q1 2022 | $240,000 | +2.1% | 2,732 | +1.8% | 0.19% | +6.6% |
| Q4 2021 | $235,000 | +11.9% | 2,683 | +4.6% | 0.18% | +2.8% |
| Q3 2021 | $210,000 | -10.3% | 2,565 | +0.2% | 0.18% | -8.8% |
| Q2 2021 | $234,000 | +8.3% | 2,560 | +1.3% | 0.19% | +0.5% |
| Q1 2021 | $216,000 | -11.8% | 2,526 | -3.7% | 0.19% | -17.2% |
| Q4 2020 | $245,000 | – | 2,622 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |